Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
JOINN Laboratories (China) Co., Ltd. Class H ( (HK:6127) ) has shared an update.
JOINN Laboratories (China) Co., Ltd. has announced a final cash dividend of RMB 0.03 per share for the financial year ending December 31, 2024. The announcement includes details on the ex-dividend date, record date, and payment date, with the dividend payment scheduled for August 31, 2025. The company will withhold a 10% PRC enterprise income tax for non-resident enterprise shareholders, but no individual income tax will be withheld for overseas individual shareholders. This dividend announcement reflects the company’s commitment to returning value to its shareholders and may influence its market positioning and stakeholder relations.
The most recent analyst rating on (HK:6127) stock is a Buy with a HK$8.57 price target. To see the full list of analyst forecasts on JOINN Laboratories (China) Co., Ltd. Class H stock, see the HK:6127 Stock Forecast page.
More about JOINN Laboratories (China) Co., Ltd. Class H
JOINN Laboratories (China) Co., Ltd. operates in the biotechnology and pharmaceutical research industry, providing laboratory services and research support for drug development and testing. The company focuses on delivering high-quality laboratory services to pharmaceutical companies and research institutions, aiming to enhance drug discovery and development processes.
Average Trading Volume: 5,021,234
Technical Sentiment Signal: Buy
Current Market Cap: HK$13.22B
For a thorough assessment of 6127 stock, go to TipRanks’ Stock Analysis page.